Ligand ID: 0U9 Drugbank ID: DB01128(Bicalutamide) Indication:For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 1uk4 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | TYR A 54LEU A 57THR A 25GLU A 47THR A 45 | 1.42A | 21.46 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 1wnc | E2 GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A 930ALA B 926THR B 923ALA A 926THR A 923 | 1.48A | 13.79 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 1zv8 | E2 GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU K 30ALA G 26THR G 23ALA K 26THR K 23 | 1.36A | 7.46 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 2beq | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU C 930ALA A 926THR A 923ALA C 926THR C 923 | 1.35A | 5.92 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 12 | TYR A 54LEU A 57THR A 24GLU A 47THR A 45 | 1.54A | 21.46 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 503ARG A 460THR A 449GLU A 457THR A 453 | 1.42A | 23.36 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | TYR A 54LEU A 57THR A 25GLU A 47THR A 45 | 1.50A | 21.68 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3i6k | HLA, A-2MEMBRANEGLYCOPROTEIN PEPTIDE (Homosapiens;SARS-COVTJF) | 5 / 12 | LEU A 160ARG A 157ALA C 2GLU A 154ALA A 158 | 1.47A | 23.15 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | TYR A 54LEU A 57THR A 25GLU A 47THR A 45 | 1.59A | 21.46 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | TYR B 54LEU B 57THR B 25GLU B 47THR B 45 | 1.44A | 21.68 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3sci | ACE2 (Homosapiens) | 5 / 12 | LEU A 503ARG A 460THR A 449GLU A 457THR A 453 | 1.44A | 22.52 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 503ARG A 460THR A 449GLU A 457THR A 453 | 1.50A | 22.20 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 4ovz | PAPAIN-LIKEPROTEINASE (SARS-COVUrbani) | 5 / 12 | PHE A 305ARG A 167ALA A 120GLU A 168THR A 169 | 1.55A | 21.48 | NoneDMS B 906 (-3.4A)NoneDMS A 903 (-3.6A)None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 5x4s | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | PHE A 89ALA A 237THR A 247ALA A 250THR A 71 | 1.60A | 19.08 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | TYR C 622LEU C 615THR C 604ALA C 609THR C 608 | 1.61A | 16.25 | NoneNoneNAG C1301 (-3.7A)NoneNone | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 5zvm | PAN-COV INHIBITORYPEPTIDE EK1SPIKE GLYCOPROTEIN (SARSr-CoV;syntheticconstruct) | 5 / 12 | LEU c 25ALA A 926THR A 925GLU A 918THR A 921 | 1.56A | 8.44 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 5zvm | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU C 930ALA B 926THR B 923ALA C 926THR C 923 | 1.33A | 12.41 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A1016PHE A 870VAL A 767ALA A 858THR A 856 | 1.49A | 16.36 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | PHE B 89ALA B 237THR B 247ALA B 250THR B 71 | 1.56A | 17.05 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU B1016PHE B 870VAL B 767ALA B 858THR B 856 | 1.52A | 16.67 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | LEU A 130ALA A 108GLU A 136ALA A 134THR A 137 | 1.24A | 20.22 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | LEU C 244PHE C 327VAL C 324ALA C 406THR C 408 | 1.42A | 21.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m1d | ACE2 (Homosapiens) | 5 / 12 | LEU B 503ARG B 460THR B 449GLU B 457THR B 453 | 1.53A | 21.22 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 12 | VAL A 398ARG B 190ALA A 382ALA B 125THR B 124 | 1.50A | 20.08 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6vw1 | ACE2 (Homosapiens) | 5 / 12 | LEU B 503ARG B 460THR B 449GLU B 457THR B 453 | 1.46A | 22.03 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | LEU L 135PHE L 118VAL H 181ALA H 137THR H 135 | 1.74A | 18.50 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | PHE L 139LEU L 135VAL H 181ALA H 137THR H 135 | 1.71A | 18.50 | None |